| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 117.91B | 111.74B | 95.20B | 81.34B | 83.60B | 84.67B |
| Gross Profit | 32.78B | 30.47B | 25.12B | 19.34B | 22.07B | 22.22B |
| EBITDA | 18.04B | 16.65B | 12.20B | 7.42B | 10.46B | 11.23B |
| Net Income | 10.48B | 9.47B | 6.01B | 4.00B | 5.35B | 6.22B |
Balance Sheet | ||||||
| Total Assets | 142.46B | 143.35B | 139.69B | 123.99B | 125.17B | 122.52B |
| Cash, Cash Equivalents and Short-Term Investments | 27.68B | 29.89B | 26.38B | 19.96B | 29.28B | 23.32B |
| Total Debt | 7.79B | 495.00M | 1.63B | 315.00M | 6.76B | 6.65B |
| Total Liabilities | 45.23B | 45.65B | 48.11B | 39.77B | 43.26B | 43.14B |
| Stockholders Equity | 96.00B | 96.53B | 90.51B | 83.22B | 80.95B | 78.05B |
Cash Flow | ||||||
| Free Cash Flow | 9.48B | 9.54B | 8.24B | -131.00M | 9.78B | 10.94B |
| Operating Cash Flow | 10.43B | 11.39B | 11.17B | 2.14B | 10.54B | 11.67B |
| Investing Cash Flow | -828.00M | -1.49B | -3.48B | -2.67B | -685.00M | -611.00M |
| Financing Cash Flow | -9.46B | -6.00B | -1.49B | -8.96B | -3.63B | -3.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥122.39B | 13.95 | ― | 2.25% | 12.64% | 34.19% | |
78 Outperform | ¥70.23B | 9.50 | ― | 2.63% | -6.00% | -13.74% | |
72 Outperform | ¥163.03B | 14.12 | 10.28% | 2.77% | 2.74% | 7.86% | |
70 Outperform | ¥161.42B | 7.70 | 8.17% | 2.04% | 1.48% | 58.59% | |
70 Outperform | ¥84.00B | 4.09 | ― | 3.09% | 6.35% | -34.20% | |
70 Outperform | ¥143.88B | 11.82 | ― | 3.88% | 1.70% | 18.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |